← Leaderboards
Srikant Rangaraju
Emory University
$10,706,248
Attributed
$16,596,493
Total exposure
9
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.9M · FY2016–25$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,596,493 · 9
By mechanism
R01$10,384,483 · 4
RF1$4,380,716 · 2
K08$942,940 · 1
R21$888,354 · 2
Top collaborators
- Nicholas Thomas Seyfried6 shared
- Levi Benjamin Wood5 shared
- Yongtae Kim2 shared
- Gopal Thinakaran2 shared
- Souvarish Sarkar1 shared
Most similar at Emory University
Same institution · by research overlap
- Victor Faundez$9,790,240
- Sung Jin Park$2,529,588
- Young Charles Jang$3,537,023
- Nicholas Thomas Seyfried$21,258,516
- Daniela C Zarnescu$6,111,064
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseNeuroinflammationBrainMediatingInflammatoryNeurodegenerative DisordersMouse ModelMicrogliaPathologyCellsAmyloid Beta-ProteinNerve DegenerationIn VivoBrain CellResponseInflammatory ResponseMass Spectrum AnalysisPhenotypeDementiaCell TypeNeuropathologyMultidisciplinaryNeurons
Grant awards (25)
Neuron and microglia-specific proteomic signatures of ERK mediated mechanisms of Alzheimer's disease.$948,518
R01 · FY2025 · AG · contact PI
Microglia-specific proteomic mechanisms and biomarkers of neuroinflammation in Alzheimerâs disease$731,174
R01 · FY2025 · AG · contact PI
Microglial function of GWAS risk factor BIN1 in Alzheimer's disease pathogenesis and inflammatory signaling$708,640
R01 · FY2025 · AG
Cell Specific Proteomics highlights Molecular signatures of Manganese neurotoxicity in Dopaminergic neurons in vivo$464,133
R21 · FY2025 · ES
Neuron and microglia-specific proteomic signatures of ERK mediated mechanisms of Alzheimer's disease.$986,184
R01 · FY2024 · AG · contact PI
Microglia-specific proteomic mechanisms and biomarkers of neuroinflammation in Alzheimerâs disease$764,472
R01 · FY2024 · AG · contact PI
Targeting Kv1.3 potassium channels for neuro-immunomodulation in Alzheimer's Disease$669,045
R01 · FY2024 · NS · contact PI
Neuron and microglia-specific proteomic signatures of ERK mediated mechanisms of Alzheimerâs disease$1,063,165
R01 · FY2023 · AG · contact PI
Targeting Kv1.3 potassium channels for neuro-immunomodulation in Alzheimer's Disease$419,875
R01 · FY2023 · NS · contact PI
Targeting Kv1.3 potassium channels for neuro-immunomodulation in Alzheimer's Disease$181,309
R01 · FY2023 · NS · contact PI
Microglial function of GWAS risk factor BIN1 in Alzheimer's disease pathogenesis and inflammatory signaling$2,250,452
RF1 · FY2022 · AG
Neuron and microglia-specific proteomic signatures of ERK mediated mechanisms of Alzheimerâs disease$1,074,815
R01 · FY2022 · AG · contact PI
Targeting Kv1.3 potassium channels for neuro-immunomodulation in Alzheimer's Disease$601,184
R01 · FY2022 · NS · contact PI
Microglia-specific proteomic mechanisms and biomarkers of neuroinflammation in Alzheimerâs disease$1,116,974
RF1 · FY2021 · AG · contact PI
Neuron and microglia-specific proteomic signatures of ERK mediated mechanisms of Alzheimerâs disease$1,039,370
R01 · FY2021 · AG · contact PI
Microglia-specific proteomic mechanisms and biomarkers of neuroinflammation in Alzheimer's disease$1,013,290
RF1 · FY2021 · AG · contact PI
Targeting Kv1.3 potassium channels for neuro-immunomodulation in Alzheimer's Disease$578,386
R01 · FY2021 · NS · contact PI
Targeting Kv1.3 potassium channels for neuro-immunomodulation in Alzheimer's Disease$618,346
R01 · FY2020 · NS · contact PI
Microglial and macrophage potassium channels as regulators of neuroinflammation in Alzheimer's Disease$188,652
K08 · FY2020 · NS · contact PI
Microglial and macrophage potassium channels as regulators of neuroinflammation in Alzheimer's Disease$188,492
K08 · FY2019 · NS · contact PI
Advanced Delivery of Microglial Kv1.3 Channel Blocker for Attenuation of Neuroinflammation of Alzheimer's Disease$185,075
R21 · FY2019 · AG
Advanced Delivery of Microglial Kv1.3 Channel Blocker for Attenuation of Neuroinflammation of Alzheimer's Disease$239,146
R21 · FY2018 · AG
Microglial and macrophage potassium channels as regulators of neuroinflammation in Alzheimer's Disease$188,652
K08 · FY2018 · NS · contact PI
Microglial and macrophage potassium channels as regulators of neuroinflammation in Alzheimer's Disease$188,492
K08 · FY2017 · NS · contact PI
Microglial and macrophage potassium channels as regulators of neuroinflammation in Alzheimer's Disease$188,652
K08 · FY2016 · NS · contact PI